| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.33 | 0.006 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.006 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.097 | 0.007 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.008 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.097 | 0.008 |